M
Meenu Mehta
Researcher at University of Technology, Sydney
Publications - 106
Citations - 3299
Meenu Mehta is an academic researcher from University of Technology, Sydney. The author has contributed to research in topics: Drug delivery & Medicine. The author has an hindex of 18, co-authored 99 publications receiving 1835 citations. Previous affiliations of Meenu Mehta include Lovely Professional University & Maharshi Dayanand University.
Papers
More filters
Journal ArticleDOI
Antibacterial and antioxidant potential of biosynthesized copper nanoparticles mediated through Cissus arnotiana plant extract.
Shanmugam Rajeshkumar,Soumya Menon,S. Venkat Kumar,Murtaza M. Tambuwala,Hamid A. Bakshi,Meenu Mehta,Saurabh Satija,Gaurav Gupta,Dinesh Kumar Chellappan,Lakshmi Thangavelu,Kamal Dua,Kamal Dua +11 more
TL;DR: This is the first study reported on C. arnotiana mediated biosynthesis of copper nanoparticles, where it is predicted that the findings can pave way for a new direction in the field of nanotechnology and nanomedicine where there is a significant potential for antibacterial and antioxidant activities.
Journal ArticleDOI
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.
Meenu Mehta,Deeksha,Devesh Tewari,Gaurav Gupta,Rajendra Awasthi,Harjeet Singh,Parijat Pandey,Dinesh Kumar Chellappan,Ridhima Wadhwa,Trudi Collet,Philip M. Hansbro,S. Rajesh Kumar,Lakshmi Thangavelu,Poonam Negi,Kamal Dua,Kamal Dua,Kamal Dua,Saurabh Satija +17 more
TL;DR: Various novel dosage forms like nanoparticles, liposomes that can be used efficiently for the delivery of various oligonucleotides such as siRNA and miRNA are focused on.
Journal ArticleDOI
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Parvarish Sharma,Meenu Mehta,Daljeet Singh Dhanjal,Simran Kaur,Gaurav Gupta,Harjeet Singh,Lakshmi Thangavelu,Shanmugam Rajeshkumar,Murtaza M. Tambuwala,Hamid A. Bakshi,Dinesh Kumar Chellappan,Kamal Dua,Saurabh Satija +12 more
TL;DR: In this review, various modes of nano drug delivery options like liposomes, dendrimers, quantum dots, carbon nanotubes and metallic nanoparticles have been discussed.
Journal ArticleDOI
The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress
Kamal Dua,Kamal Dua,Kamal Dua,Ridhima Wadhwa,Gautam Singhvi,Vamshikrishna Rapalli,Shakti D. Shukla,Madhur D. Shastri,Gaurav Gupta,Saurabh Satija,Meenu Mehta,Navneet Khurana,Rajendra Awasthi,Pawan Kumar Maurya,Lakshmi Thangavelu,Shanmugam Rajeshkumar,Murtaza M. Tambuwala,Trudi Collet,Philip M. Hansbro,Philip M. Hansbro,Philip M. Hansbro,Dinesh Kumar Chellappan +21 more
TL;DR: The different siRNA nanocarrier systems for chronic respiratory diseases, for safe and effective delivery are discussed, and siRNA mediated pro‐inflammatory gene or miRNA targeting approach can be a useful approach in combating chronic respiratory inflammatory conditions.
Journal ArticleDOI
Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems
Kamal Dua,Kamal Dua,Kamal Dua,Vamshikrishna Malyla,Gautam Singhvi,Ridhima Wadhwa,Rapalli Vamshi Krishna,Shakti D. Shukla,Madhur D. Shastri,Dinesh Kumar Chellappan,Pawan Kumar Maurya,Saurabh Satija,Meenu Mehta,Monica Gulati,Nicole G. Hansbro,Trudi Collet,Rajendra Awasthi,Gaurav Gupta,Alan Hsu,Philip M. Hansbro +19 more
TL;DR: Recent trends in various novel drug delivery carriers including microparticles, microemulsions, microspheres, nanoparticles, liposomes, dendrimers, solid lipid nanocarriers etc which can help in combating the oxidative stress in CRDs and ultimately reducing the disease burden and improving the quality of life with CRDs patients are highlighted.